Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
In Alzheimer's disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers. Several methods and platforms exist to measure those biomarkers, leading to challenges in combining data across studies. Thus, there is a need to...
Main Authors: | Jigyasha Timsina, Muhammad Ali, Anh Do, Lihua Wang, Daniel Western, Yun Ju Sung, Carlos Cruchaga |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996123003893 |
Similar Items
-
Harmonized Z-Scores Calculated from a Large-Scale Normal MRI Database to Evaluate Brain Atrophy in Neurodegenerative Disorders
by: Norihide Maikusa, et al.
Published: (2022-09-01) -
Association of CSF biomarkers with MRI brain changes in Alzheimer's disease
by: Nazib M Seidu, et al.
Published: (2024-01-01) -
Current Biomarkers for Alzheimer’s Disease: From CSF to Blood
by: Kun Zou, et al.
Published: (2020-08-01) -
Blood and CSF Homocysteine Levels in Alzheimer’s Disease: A Meta-Analysis and Meta-Regression of Case–Control Studies
by: Zhang L, et al.
Published: (2022-10-01) -
Gray-white matter boundary Z-score and volume as imaging biomarkers of Alzheimer’s disease
by: Yunan Tian, et al.
Published: (2023-12-01)